Phase 2b clinical trial of GH001 in patients with treatment-resistant depression completed enrolment of the double-blind phase in Q3 2024 Phase 1 clinical trial to evaluate proprietary aerosol ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback